raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:254925

Combined oxidative phosphorylation defect type 4

Synonyms: COXPD4

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Neonatal
Status
active

Combined oxidative phosphorylation defect type 4 is a rare mitochondrial disorder due to a defect in mitochondrial protein synthesis characterized by a neonatal onset of severe metabolic acidosis and respiratory distress, persistent lactic acidosis with episodes of metabolic crises, developmental regression, microcephaly, abnormal gaze fixation and pursuit, axial hypotonia with limb spasticity and reduced spontaneous movements. Neuroimaging studies reveal polymicrogyria, white matter abnormalities and multiple cystic brain lesions, including basal ganglia, and cerebral atrophy. Decreased activity of complex I and IV have been determined in muscle biopsy.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCombined oxidative phosphorylation defect type 4COXPD4
frDéficit combiné de la phosphorylation oxydative type 4= en
deKombinierter Defekt der oxidativen Phosphorylierung Typ 4= en
esDeficiencia combinada de la fosforilación oxidativa tipo 4= en
itDifetto combinato della fosforilazione ossidativa, tipo 4= en
nlGecombineerde oxidatieve fosforylatiedeficiëntie type 4COXPD4 · Gecombineerd defect in oxidatieve fosforylering type 4
ptDeficiência combinada da fosforilação oxidativa, tipo 4= en
plZłożony defekt fosforylacji oksydacyjnej typu 4= en
csKombinovaný defekt oxidativní fosforylace, typ 4= en
ukКомбінований дефект окисного фосфорилювання, тип 4= en
zh结合氧化磷酸化不足4= en
trKombine oksidatif fosforilasyon defekti tip 4= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM610678Evalidated
ICD-10E88.8NTBTattributedvalidated
ICD-115C53.23NTBTindexvalidated
MONDO0012534Evalidated
MeSHC565690Evalidated
UMLSC1857682Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
TUFMDisease-causing germline mutation(s) inAssessedHGNC:12420ENSG0000017895260238916p11.2Tu translation elongation factor, mitochondrial17160893[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families2 casesWorldwideCase(s)Validated17160893[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_17160893[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card